- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hormone Receptor-positive Breast Cancer in New Zealand
Total 2965 results
-
Roswell Park Cancer InstituteAstraZeneca; National Center for Complementary and Integrative Health (NCCIH)Completed
-
PfizerActive, not recruitingHR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast CancerUnited States, Japan, Canada, Russian Federation, Bulgaria, Ukraine
-
Providence Health & ServicesBristol-Myers Squibb; Memorial Sloan Kettering Cancer CenterActive, not recruitingBreast Cancer | Breast Carcinoma | Breast Neoplasm Female | Breast TumorUnited States
-
Fox Chase Cancer CenterPfizer; National Comprehensive Cancer NetworkCompletedMetastatic Breast CancerUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)RecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Unresectable Triple-Negative Breast CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterUnited States Department of DefenseActive, not recruitingBreast Cancer | Metastatic HER2-negative BreastUnited States
-
US Oncology ResearchBristol-Myers Squibb; PfizerActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterUniversity of Chicago; New York UniversityActive, not recruitingNon-Metastatic Breast CancerUnited States
-
PfizerAstellas Pharma Inc; Medivation, Inc.Withdrawn
-
German Breast GroupCompletedMetastatic Breast CancerGermany
-
Southwest Oncology GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology Group; Cancer and... and other collaboratorsCompletedBreast Cancer | Infertility | Menopausal SymptomsItaly, Australia, Switzerland, Belgium, Hungary, New Zealand
-
German Breast GroupTerminatedMetastatic Breast CancerGermany
-
Weill Medical College of Cornell UniversityRecruiting
-
Memorial Sloan Kettering Cancer CenterPfizer; AmgenCompletedDose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: FeasibilityBreast Cancer | Adenocarcinoma of the BreastUnited States
-
Memorial Sloan Kettering Cancer CenterGRAIL, LLCActive, not recruitingBreast Cancer | Breast BenignUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast CancerUnited States
-
Proton Collaborative GroupRecruiting
-
Columbia UniversityNational Cancer Institute (NCI)Recruiting
-
NYU Langone HealthRecruitingBreast CancerUnited States
-
PfizerCompleted
-
Icahn School of Medicine at Mount SinaiNational Institute on Minority Health and Health Disparities (NIMHD)CompletedBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterMARTELL FOUNDATIONActive, not recruiting
-
PfizerTerminatedBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of Washington; Sarah Lawrence CollegeCompletedBreast CancerUnited States
-
NYU Langone HealthCompletedBreast CancerUnited States
-
NYU Langone HealthCompletedBreast CancerUnited States
-
NYU Langone HealthCompleted
-
NYU Langone HealthTerminatedBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterGE HealthcareCompletedBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterTerminatedBreast CancerUnited States
-
Columbia UniversityGlaxoSmithKlineTerminated
-
NYU Langone HealthNovartis PharmaceuticalsCompleted
-
Memorial Sloan Kettering Cancer CenterRalph Lauren Center for Cancer Care and Prevention; North General Hospital,...CompletedBreast CancerUnited States
-
NYU Langone HealthNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Weill Medical College of Cornell UniversityCompleted
-
Triumvira Immunologics, Inc.Merck Sharp & Dohme LLCActive, not recruitingHER2 Positive Gastric Cancer | Metastatic HER2 Positive Gastroesophageal Junction CancerUnited States, Canada
-
NRG OncologyNational Cancer Institute (NCI)SuspendedStage II Breast Cancer | Stage IIIA Breast Cancer | Invasive Breast Carcinoma | Stage IIA Breast Cancer | Stage IIB Breast CancerUnited States, Canada
-
Dompé Farmaceutici S.p.ATerminatedBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterJohns Hopkins University; University of British Columbia; University of Pittsburgh and other collaboratorsCompletedBreast Surgery | Breast Cancer | Breast Augmentation | Breast Reconstruction | Breast ReductionUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterUniversity of Pennsylvania; Genentech, Inc.CompletedBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterAmgenCompleted
-
Memorial Sloan Kettering Cancer CenterSynta Pharmaceuticals Corp.Completed
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Invasive Adenocarcinoma of the BreastUnited States
-
PfizerTerminatedAdvanced Breast CancerUnited States, Hungary, Spain, Belgium, China, Hong Kong, Australia, Poland, Canada, India, South Africa